Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Coagulation Testing Market by Product (Instruments, Consumables), by Application (Prothrombin Time, Activated Partial Thromboplastin Time, Thrombin Time, Activated Clotting Time), by End User (Hospitals, Clinical Laboratories, Point-of-Care Testing, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

A03148

Pages: 280

Charts: 67

Tables: 151

Coagulation Testing Market Research, 2031

The global coagulation testing market size was valued at $3.1 billion in 2021, and is projected to reach $8.8 billion by 2031, growing at a CAGR of 11.5% from 2022 to 2031.Blood Coagulation, also known as clotting, is a change in the physical properties of blood caused by the conversion of fibrinogen, a soluble plasma protein, into fibrin, a solid gel. A coagulometer is used to examine the ability of the blood to clot and the blood clotting time.

[COVIDIMPACTSTATEMENT]

Get more information on this report : Request Sample Pages

Blood's ability to clot and how long it takes to clot are both assessed by coagulation tests. This test aids the physician in determining the likelihood of blood vessel thrombosis or severe bleeding. Testing aids medical professionals in determining the likelihood of excessive bleeding and the formation of blood vessel clots, or thrombosis. Some common coagulation test types are complete blood count (CBC), fibrinogen level, Factor V assay, prothrombin time, platelet count, thrombin time, and bleeding time.

The global market for coagulation testing market forecast to experience rapid growth due to the prevalence of chronic blood illnesses. The market for coagulation testing is expected to increase as a result of rise in need for specialized hematology and coagulation laboratories. Point of care (POC) devices are created using cutting-edge technologies such as fluorescence microscopy, microfluidics, electrochemical sensing, and photoacoustic detection. POC instruments primarily gauge the optical, mechanical, and electrochemical aspects of blood clotting. These technical developments are anticipated to accelerate the market expansion for coagulation testing market growth.

The global coagulation testing industry's expansion is expected to be constrained by the higher cost of coagulation instruments and a lack of expertise. The growth of the global coagulation testing market size may be hindered by a shortage of competent workers and increased device costs.

The coagulation testing market opportunity is expected to benefit greatly from recent innovations such as smartphone-enabled coagulation tests. It is projected that the smartphone-based blood coagulation test will propel market expansion. This self-testing method uses an instrument to track blood flow in individuals receiving anticoagulant medication. Patients have the option to conduct this test at home due to the device.

The key players profiled in this report include Thermo Fisher Scientific Inc., Helena Laboratories Corporation., Micropoint Biosciences, Medtronic, F. Hoffmann-La Roche Ltd, Nihon Kohden Corporation., Abbott., Sysmex Corporation, Bd Biosciences., and Danaher.

The global coagulation testing market is segmented on the basis of product type, application, end-use industry, and region. By product type, the market is sub-segmented into instruments and consumables. By application, the market is classified into prothrombin time, activated partial thromboplastin time, thrombin time, and activated clotting time. By end-user, the market is classified into hospitals, clinical laboratories, point-of-care testing, and others. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The coagulation testing market is segmented into Product, Application and End User.

[PRODUCTGRAPH]

By product type, the consumables segment dominated the global coagulation testing market share in 2021. Consumables include reagents and strains. All testing techniques require reagents hence, consumables for coagulation testing are widely used and frequently ordered.Tremendous growth in diagnostic centers across the globe; enhanced diagnostic tools; improved treatment monitoring; and heavy investments in the R&D are anticipated to drive the growth of global market.

[APPLICATIONGRAPH]

The prothrombin time segment dominated the global coagulation testing market share in 2021. Prothrombin time is one of numerous blood tests used in clinical practice to assess patients' coagulation status. Increase in economic pressures on hospitals and rise in competition among therapists and suppliers are expected to drive the growth of global market. Moreover, clinicians are reviewing developing technologies, and also ensuring that patients benefit from new advancements. Furthermore, perioperative coagulation prothrombin time offers complex interactions within the clotting system, reduces turnaround test times, and reduces inappropriate transfusion.

[ENDUSERGRAPH]

By end-user, the hospitals sub-segment dominated the global coagulation testing market share in 2021. Clotting time tests, such as prothrombin time, are widely used to evaluate the hemostatic system in an outpatient or hospital context. Newly developed prothrombin time testing equipment with sensor technology are faster and easier to use. Furthermore, the rising prevalence of cardiovascular ailments, blood disorders, and increased demand for hospital is projected to fuel the growth of the global market, during the forecast period.

[REGIONGRAPH]

By region, Europe dominated the global coagulation testing market in 2021 and is projected to remain the dominant-growing sub-segment during the forecast period. This is majorly due to the latest advancements and strategies and the most current updates in the field. Annually, cardiovascular disease (CVD) accounts for 3.9 million deaths in Europe i.e. CVD causes 45% of all deaths in Europe. In addition, death rates from both ischemic heart disease and stroke are generally higher in Eastern and Central Europe; these deaths are anticipated to drive the demand for coagulation tests services and eventually boost the growth of coagulation tests in Europe market.

Impact of COVID-19 on the Global Coagulation Testing Industry

  • The COVID-19 pandemic has positively affected the global coagulation testing market. Many scientists are focusing on identifying the coagulopathy behavior linked to the novel coronavirus.
  • Researchers are responsible for monitoring several coagulation tests such as prothrombin time (PT), platelet count, fibrinogen, and D-dimer methods to find the sensitivity of coagulation testing in hospitalized patients due to COVID-19.
  • They have found that patients who have higher D-dimer have high chance of mortality. This element is a major driver of the need for coagulation testing procedures for early diagnosis and is anticipated to fuel market expansion during this moment of economic crisis.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the coagulation testing market analysis from 2021 to 2031 to identify the prevailing coagulation testing market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the coagulation testing market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global coagulation testing market trends, key players, market segments, application areas, and market growth strategies.

 Key Market Segments

  • By Product
    • Instruments
    • Consumables
  • By Application
    • Prothrombin Time
    • Activated Partial Thromboplastin Time
    • Thrombin Time
    • Activated Clotting Time
  • By End User
    • Hospitals
    • Clinical Laboratories
    • Point-of-Care Testing
    • Others
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • United Kingdom
      • France
      • Spain
      • Italy
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest Of Asia Pacific
    • LAMEA
      • Brazil
      • Saudi Arabia
      • UAE
      • South Africa
      • Rest of LAMEA

 
Key Market Players

  • Thermo Fisher Scientific Inc.
  • Alere Inc.
  • Nihon Kohden Corporation
  • Sysmex Corporation
  • Medtronic plc
  • F. Hoffmann-La Roche Ltd.
  • Abbott Laboratories
  • Helena Laboratories
  • Micropoint Biosciences
  • Diagnostica Stago Sas

  • CHAPTER 1:INTRODUCTION

    • 1.1.Report description

    • 1.2.Key market segments

    • 1.3.Key benefits to the stakeholders

    • 1.4.Research Methodology

      • 1.4.1.Secondary research

      • 1.4.2.Primary research

      • 1.4.3.Analyst tools and models

  • CHAPTER 2:EXECUTIVE SUMMARY

    • 2.1.Key findings of the study

    • 2.2.CXO Perspective

  • CHAPTER 3:MARKET OVERVIEW

    • 3.1.Market definition and scope

    • 3.2.Key findings

      • 3.2.1.Top investment pockets

    • 3.3.Porter’s five forces analysis

    • 3.4.Top player positioning

    • 3.5.Market dynamics

      • 3.5.1.Drivers

      • 3.5.2.Restraints

      • 3.5.3.Opportunities

    • 3.6.COVID-19 Impact Analysis on the market

    • 3.7.Value Chain Analysis

    • 3.8.Market Share Analysis

    • 3.9.Regulatory Guidelines

    • 3.10.Key Regulation Analysis

    • 3.11.Patent Landscape

  • CHAPTER 4: COAGULATION TESTING MARKET, BY PRODUCT

    • 4.1 Overview

      • 4.1.1 Market size and forecast

    • 4.2 Instruments

      • 4.2.1 Key market trends, growth factors and opportunities

      • 4.2.2 Market size and forecast, by region

      • 4.2.3 Market analysis by country

    • 4.3 Consumables

      • 4.3.1 Key market trends, growth factors and opportunities

      • 4.3.2 Market size and forecast, by region

      • 4.3.3 Market analysis by country

  • CHAPTER 5: COAGULATION TESTING MARKET, BY APPLICATION

    • 5.1 Overview

      • 5.1.1 Market size and forecast

    • 5.2 Prothrombin Time

      • 5.2.1 Key market trends, growth factors and opportunities

      • 5.2.2 Market size and forecast, by region

      • 5.2.3 Market analysis by country

    • 5.3 Activated Partial Thromboplastin Time

      • 5.3.1 Key market trends, growth factors and opportunities

      • 5.3.2 Market size and forecast, by region

      • 5.3.3 Market analysis by country

    • 5.4 Thrombin Time

      • 5.4.1 Key market trends, growth factors and opportunities

      • 5.4.2 Market size and forecast, by region

      • 5.4.3 Market analysis by country

    • 5.5 Activated Clotting Time

      • 5.5.1 Key market trends, growth factors and opportunities

      • 5.5.2 Market size and forecast, by region

      • 5.5.3 Market analysis by country

  • CHAPTER 6: COAGULATION TESTING MARKET, BY END USER

    • 6.1 Overview

      • 6.1.1 Market size and forecast

    • 6.2 Hospitals

      • 6.2.1 Key market trends, growth factors and opportunities

      • 6.2.2 Market size and forecast, by region

      • 6.2.3 Market analysis by country

    • 6.3 Clinical Laboratories

      • 6.3.1 Key market trends, growth factors and opportunities

      • 6.3.2 Market size and forecast, by region

      • 6.3.3 Market analysis by country

    • 6.4 Point-of-Care Testing

      • 6.4.1 Key market trends, growth factors and opportunities

      • 6.4.2 Market size and forecast, by region

      • 6.4.3 Market analysis by country

    • 6.5 Others

      • 6.5.1 Key market trends, growth factors and opportunities

      • 6.5.2 Market size and forecast, by region

      • 6.5.3 Market analysis by country

  • CHAPTER 7: COAGULATION TESTING MARKET, BY REGION

    • 7.1 Overview

      • 7.1.1 Market size and forecast

    • 7.2 North America

      • 7.2.1 Key trends and opportunities

      • 7.2.2 North America Market size and forecast, by Product

      • 7.2.3 North America Market size and forecast, by Application

      • 7.2.4 North America Market size and forecast, by End User

      • 7.2.5 North America Market size and forecast, by country

        • 7.2.5.1 U.S.
          • 7.2.5.1.1 Market size and forecast, by Product
          • 7.2.5.1.2 Market size and forecast, by Application
          • 7.2.5.1.3 Market size and forecast, by End User
        • 7.2.5.2 Canada
          • 7.2.5.2.1 Market size and forecast, by Product
          • 7.2.5.2.2 Market size and forecast, by Application
          • 7.2.5.2.3 Market size and forecast, by End User
        • 7.2.5.3 Mexico
          • 7.2.5.3.1 Market size and forecast, by Product
          • 7.2.5.3.2 Market size and forecast, by Application
          • 7.2.5.3.3 Market size and forecast, by End User

    • 7.3 Europe

      • 7.3.1 Key trends and opportunities

      • 7.3.2 Europe Market size and forecast, by Product

      • 7.3.3 Europe Market size and forecast, by Application

      • 7.3.4 Europe Market size and forecast, by End User

      • 7.3.5 Europe Market size and forecast, by country

        • 7.3.5.1 Germany
          • 7.3.5.1.1 Market size and forecast, by Product
          • 7.3.5.1.2 Market size and forecast, by Application
          • 7.3.5.1.3 Market size and forecast, by End User
        • 7.3.5.2 United Kingdom
          • 7.3.5.2.1 Market size and forecast, by Product
          • 7.3.5.2.2 Market size and forecast, by Application
          • 7.3.5.2.3 Market size and forecast, by End User
        • 7.3.5.3 France
          • 7.3.5.3.1 Market size and forecast, by Product
          • 7.3.5.3.2 Market size and forecast, by Application
          • 7.3.5.3.3 Market size and forecast, by End User
        • 7.3.5.4 Spain
          • 7.3.5.4.1 Market size and forecast, by Product
          • 7.3.5.4.2 Market size and forecast, by Application
          • 7.3.5.4.3 Market size and forecast, by End User
        • 7.3.5.5 Italy
          • 7.3.5.5.1 Market size and forecast, by Product
          • 7.3.5.5.2 Market size and forecast, by Application
          • 7.3.5.5.3 Market size and forecast, by End User
        • 7.3.5.6 Rest of Europe
          • 7.3.5.6.1 Market size and forecast, by Product
          • 7.3.5.6.2 Market size and forecast, by Application
          • 7.3.5.6.3 Market size and forecast, by End User

    • 7.4 Asia-Pacific

      • 7.4.1 Key trends and opportunities

      • 7.4.2 Asia-Pacific Market size and forecast, by Product

      • 7.4.3 Asia-Pacific Market size and forecast, by Application

      • 7.4.4 Asia-Pacific Market size and forecast, by End User

      • 7.4.5 Asia-Pacific Market size and forecast, by country

        • 7.4.5.1 China
          • 7.4.5.1.1 Market size and forecast, by Product
          • 7.4.5.1.2 Market size and forecast, by Application
          • 7.4.5.1.3 Market size and forecast, by End User
        • 7.4.5.2 Japan
          • 7.4.5.2.1 Market size and forecast, by Product
          • 7.4.5.2.2 Market size and forecast, by Application
          • 7.4.5.2.3 Market size and forecast, by End User
        • 7.4.5.3 India
          • 7.4.5.3.1 Market size and forecast, by Product
          • 7.4.5.3.2 Market size and forecast, by Application
          • 7.4.5.3.3 Market size and forecast, by End User
        • 7.4.5.4 South Korea
          • 7.4.5.4.1 Market size and forecast, by Product
          • 7.4.5.4.2 Market size and forecast, by Application
          • 7.4.5.4.3 Market size and forecast, by End User
        • 7.4.5.5 Australia
          • 7.4.5.5.1 Market size and forecast, by Product
          • 7.4.5.5.2 Market size and forecast, by Application
          • 7.4.5.5.3 Market size and forecast, by End User
        • 7.4.5.6 Rest Of Asia Pacific
          • 7.4.5.6.1 Market size and forecast, by Product
          • 7.4.5.6.2 Market size and forecast, by Application
          • 7.4.5.6.3 Market size and forecast, by End User

    • 7.5 LAMEA

      • 7.5.1 Key trends and opportunities

      • 7.5.2 LAMEA Market size and forecast, by Product

      • 7.5.3 LAMEA Market size and forecast, by Application

      • 7.5.4 LAMEA Market size and forecast, by End User

      • 7.5.5 LAMEA Market size and forecast, by country

        • 7.5.5.1 Brazil
          • 7.5.5.1.1 Market size and forecast, by Product
          • 7.5.5.1.2 Market size and forecast, by Application
          • 7.5.5.1.3 Market size and forecast, by End User
        • 7.5.5.2 Saudi Arabia
          • 7.5.5.2.1 Market size and forecast, by Product
          • 7.5.5.2.2 Market size and forecast, by Application
          • 7.5.5.2.3 Market size and forecast, by End User
        • 7.5.5.3 UAE
          • 7.5.5.3.1 Market size and forecast, by Product
          • 7.5.5.3.2 Market size and forecast, by Application
          • 7.5.5.3.3 Market size and forecast, by End User
        • 7.5.5.4 South Africa
          • 7.5.5.4.1 Market size and forecast, by Product
          • 7.5.5.4.2 Market size and forecast, by Application
          • 7.5.5.4.3 Market size and forecast, by End User
        • 7.5.5.5 Rest of LAMEA
          • 7.5.5.5.1 Market size and forecast, by Product
          • 7.5.5.5.2 Market size and forecast, by Application
          • 7.5.5.5.3 Market size and forecast, by End User

  • CHAPTER 8: COMPANY LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top winning strategies

    • 8.3. Product Mapping of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Key developments

  • CHAPTER 9: COMPANY PROFILES

    • 9.1 Alere Inc.

      • 9.1.1 Company overview

      • 9.1.2 Company snapshot

      • 9.1.3 Operating business segments

      • 9.1.4 Product portfolio

      • 9.1.5 Business performance

      • 9.1.6 Key strategic moves and developments

    • 9.2 Nihon Kohden Corporation

      • 9.2.1 Company overview

      • 9.2.2 Company snapshot

      • 9.2.3 Operating business segments

      • 9.2.4 Product portfolio

      • 9.2.5 Business performance

      • 9.2.6 Key strategic moves and developments

    • 9.3 F. Hoffmann-La Roche Ltd.

      • 9.3.1 Company overview

      • 9.3.2 Company snapshot

      • 9.3.3 Operating business segments

      • 9.3.4 Product portfolio

      • 9.3.5 Business performance

      • 9.3.6 Key strategic moves and developments

    • 9.4 Sysmex Corporation

      • 9.4.1 Company overview

      • 9.4.2 Company snapshot

      • 9.4.3 Operating business segments

      • 9.4.4 Product portfolio

      • 9.4.5 Business performance

      • 9.4.6 Key strategic moves and developments

    • 9.5 Thermo Fisher Scientific Inc.

      • 9.5.1 Company overview

      • 9.5.2 Company snapshot

      • 9.5.3 Operating business segments

      • 9.5.4 Product portfolio

      • 9.5.5 Business performance

      • 9.5.6 Key strategic moves and developments

    • 9.6 Diagnostica Stago Sas

      • 9.6.1 Company overview

      • 9.6.2 Company snapshot

      • 9.6.3 Operating business segments

      • 9.6.4 Product portfolio

      • 9.6.5 Business performance

      • 9.6.6 Key strategic moves and developments

    • 9.7 Helena Laboratories

      • 9.7.1 Company overview

      • 9.7.2 Company snapshot

      • 9.7.3 Operating business segments

      • 9.7.4 Product portfolio

      • 9.7.5 Business performance

      • 9.7.6 Key strategic moves and developments

    • 9.8 Abbott Laboratories

      • 9.8.1 Company overview

      • 9.8.2 Company snapshot

      • 9.8.3 Operating business segments

      • 9.8.4 Product portfolio

      • 9.8.5 Business performance

      • 9.8.6 Key strategic moves and developments

    • 9.9 Medtronic plc

      • 9.9.1 Company overview

      • 9.9.2 Company snapshot

      • 9.9.3 Operating business segments

      • 9.9.4 Product portfolio

      • 9.9.5 Business performance

      • 9.9.6 Key strategic moves and developments

    • 9.10 Micropoint Biosciences

      • 9.10.1 Company overview

      • 9.10.2 Company snapshot

      • 9.10.3 Operating business segments

      • 9.10.4 Product portfolio

      • 9.10.5 Business performance

      • 9.10.6 Key strategic moves and developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 2. COAGULATION TESTING MARKET SIZE, FOR INSTRUMENTS, BY REGION, 2021-2031 ($MILLION)
    TABLE 3. COAGULATION TESTING MARKET FOR INSTRUMENTS, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 4. COAGULATION TESTING MARKET SIZE, FOR CONSUMABLES, BY REGION, 2021-2031 ($MILLION)
    TABLE 5. COAGULATION TESTING MARKET FOR CONSUMABLES, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 6. GLOBAL COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 7. COAGULATION TESTING MARKET SIZE, FOR PROTHROMBIN TIME, BY REGION, 2021-2031 ($MILLION)
    TABLE 8. COAGULATION TESTING MARKET FOR PROTHROMBIN TIME, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 9. COAGULATION TESTING MARKET SIZE, FOR ACTIVATED PARTIAL THROMBOPLASTIN TIME, BY REGION, 2021-2031 ($MILLION)
    TABLE 10. COAGULATION TESTING MARKET FOR ACTIVATED PARTIAL THROMBOPLASTIN TIME, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 11. COAGULATION TESTING MARKET SIZE, FOR THROMBIN TIME, BY REGION, 2021-2031 ($MILLION)
    TABLE 12. COAGULATION TESTING MARKET FOR THROMBIN TIME, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 13. COAGULATION TESTING MARKET SIZE, FOR ACTIVATED CLOTTING TIME, BY REGION, 2021-2031 ($MILLION)
    TABLE 14. COAGULATION TESTING MARKET FOR ACTIVATED CLOTTING TIME, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 15. GLOBAL COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 16. COAGULATION TESTING MARKET SIZE, FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
    TABLE 17. COAGULATION TESTING MARKET FOR HOSPITALS, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 18. COAGULATION TESTING MARKET SIZE, FOR CLINICAL LABORATORIES, BY REGION, 2021-2031 ($MILLION)
    TABLE 19. COAGULATION TESTING MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 20. COAGULATION TESTING MARKET SIZE, FOR POINT-OF-CARE TESTING, BY REGION, 2021-2031 ($MILLION)
    TABLE 21. COAGULATION TESTING MARKET FOR POINT-OF-CARE TESTING, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 22. COAGULATION TESTING MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
    TABLE 23. COAGULATION TESTING MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 24. COAGULATION TESTING MARKET, BY REGION, 2021-2031 ($MILLION)
    TABLE 25. NORTH AMERICA COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 26. NORTH AMERICA COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 27. NORTH AMERICA COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 28. NORTH AMERICA COAGULATION TESTING MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 29. U.S. COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 30. U.S. COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 31. U.S. COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 32. CANADA COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 33. CANADA COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 34. CANADA COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 35. MEXICO COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 36. MEXICO COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 37. MEXICO COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 38. EUROPE COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 39. EUROPE COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 40. EUROPE COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 41. EUROPE COAGULATION TESTING MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 42. GERMANY COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 43. GERMANY COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 44. GERMANY COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 45. UNITED KINGDOM COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 46. UNITED KINGDOM COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 47. UNITED KINGDOM COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 48. FRANCE COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 49. FRANCE COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 50. FRANCE COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 51. SPAIN COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 52. SPAIN COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 53. SPAIN COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 54. ITALY COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 55. ITALY COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 56. ITALY COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 57. REST OF EUROPE COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 58. REST OF EUROPE COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 59. REST OF EUROPE COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 60. ASIA-PACIFIC COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 61. ASIA-PACIFIC COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 62. ASIA-PACIFIC COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 63. ASIA-PACIFIC COAGULATION TESTING MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 64. CHINA COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 65. CHINA COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 66. CHINA COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 67. JAPAN COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 68. JAPAN COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 69. JAPAN COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 70. INDIA COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 71. INDIA COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 72. INDIA COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 73. SOUTH KOREA COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 74. SOUTH KOREA COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 75. SOUTH KOREA COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 76. AUSTRALIA COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 77. AUSTRALIA COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 78. AUSTRALIA COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 79. REST OF ASIA PACIFIC COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 80. REST OF ASIA PACIFIC COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 81. REST OF ASIA PACIFIC COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 82. LAMEA COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 83. LAMEA COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 84. LAMEA COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 85. LAMEA COAGULATION TESTING MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 86. BRAZIL COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 87. BRAZIL COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 88. BRAZIL COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 89. SAUDI ARABIA COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 90. SAUDI ARABIA COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 91. SAUDI ARABIA COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 92. UAE COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 93. UAE COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 94. UAE COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 95. SOUTH AFRICA COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 96. SOUTH AFRICA COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 97. SOUTH AFRICA COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 98. REST OF LAMEA COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 99. REST OF LAMEA COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 100. REST OF LAMEA COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 101.ALERE INC.: COMPANY SNAPSHOT
    TABLE 102.ALERE INC.: OPERATING SEGMENTS
    TABLE 103.ALERE INC.: PRODUCT PORTFOLIO
    TABLE 104.ALERE INC.: NET SALES,
    TABLE 105.ALERE INC.: KEY STRATERGIES
    TABLE 106.NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT
    TABLE 107.NIHON KOHDEN CORPORATION: OPERATING SEGMENTS
    TABLE 108.NIHON KOHDEN CORPORATION: PRODUCT PORTFOLIO
    TABLE 109.NIHON KOHDEN CORPORATION: NET SALES,
    TABLE 110.NIHON KOHDEN CORPORATION: KEY STRATERGIES
    TABLE 111.F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
    TABLE 112.F. HOFFMANN-LA ROCHE LTD.: OPERATING SEGMENTS
    TABLE 113.F. HOFFMANN-LA ROCHE LTD.: PRODUCT PORTFOLIO
    TABLE 114.F. HOFFMANN-LA ROCHE LTD.: NET SALES,
    TABLE 115.F. HOFFMANN-LA ROCHE LTD.: KEY STRATERGIES
    TABLE 116.SYSMEX CORPORATION: COMPANY SNAPSHOT
    TABLE 117.SYSMEX CORPORATION: OPERATING SEGMENTS
    TABLE 118.SYSMEX CORPORATION: PRODUCT PORTFOLIO
    TABLE 119.SYSMEX CORPORATION: NET SALES,
    TABLE 120.SYSMEX CORPORATION: KEY STRATERGIES
    TABLE 121.THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
    TABLE 122.THERMO FISHER SCIENTIFIC INC.: OPERATING SEGMENTS
    TABLE 123.THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO
    TABLE 124.THERMO FISHER SCIENTIFIC INC.: NET SALES,
    TABLE 125.THERMO FISHER SCIENTIFIC INC.: KEY STRATERGIES
    TABLE 126.DIAGNOSTICA STAGO SAS: COMPANY SNAPSHOT
    TABLE 127.DIAGNOSTICA STAGO SAS: OPERATING SEGMENTS
    TABLE 128.DIAGNOSTICA STAGO SAS: PRODUCT PORTFOLIO
    TABLE 129.DIAGNOSTICA STAGO SAS: NET SALES,
    TABLE 130.DIAGNOSTICA STAGO SAS: KEY STRATERGIES
    TABLE 131.HELENA LABORATORIES: COMPANY SNAPSHOT
    TABLE 132.HELENA LABORATORIES: OPERATING SEGMENTS
    TABLE 133.HELENA LABORATORIES: PRODUCT PORTFOLIO
    TABLE 134.HELENA LABORATORIES: NET SALES,
    TABLE 135.HELENA LABORATORIES: KEY STRATERGIES
    TABLE 136.ABBOTT LABORATORIES: COMPANY SNAPSHOT
    TABLE 137.ABBOTT LABORATORIES: OPERATING SEGMENTS
    TABLE 138.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
    TABLE 139.ABBOTT LABORATORIES: NET SALES,
    TABLE 140.ABBOTT LABORATORIES: KEY STRATERGIES
    TABLE 141.MEDTRONIC PLC: COMPANY SNAPSHOT
    TABLE 142.MEDTRONIC PLC: OPERATING SEGMENTS
    TABLE 143.MEDTRONIC PLC: PRODUCT PORTFOLIO
    TABLE 144.MEDTRONIC PLC: NET SALES,
    TABLE 145.MEDTRONIC PLC: KEY STRATERGIES
    TABLE 146.MICROPOINT BIOSCIENCES: COMPANY SNAPSHOT
    TABLE 147.MICROPOINT BIOSCIENCES: OPERATING SEGMENTS
    TABLE 148.MICROPOINT BIOSCIENCES: PRODUCT PORTFOLIO
    TABLE 149.MICROPOINT BIOSCIENCES: NET SALES,
    TABLE 150.MICROPOINT BIOSCIENCES: KEY STRATERGIES

  • LIST OF FIGURES

  • FIGURE 1.COAGULATION TESTING MARKET SEGMENTATION
    FIGURE 2.COAGULATION TESTING MARKET,2021-2031
    FIGURE 3.COAGULATION TESTING MARKET,2021-2031
    FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
    FIGURE 5.PORTER FIVE-1
    FIGURE 6.PORTER FIVE-2
    FIGURE 7.PORTER FIVE-3
    FIGURE 8.PORTER FIVE-4
    FIGURE 9.PORTER FIVE-5
    FIGURE 10.TOP PLAYER POSITIONING
    FIGURE 11.COAGULATION TESTING MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
    FIGURE 12.VALUE CHAIN ANALYSIS
    FIGURE 13.MARKET SHARE ANALYSIS
    FIGURE 14.REGULATORY GUIDELINES
    FIGURE 15.KEY REGULATION ANALYSIS
    FIGURE 16.PATENT ANALYSIS BY COMPANY
    FIGURE 17.PATENT ANALYSIS BY COUNTRY
    FIGURE 18.COAGULATION TESTING MARKET,BY PRODUCT,2021(%)
    FIGURE 19.COMPARATIVE SHARE ANALYSIS OF INSTRUMENTS COAGULATION TESTING MARKET,2021-2031(%)
    FIGURE 20.COMPARATIVE SHARE ANALYSIS OF CONSUMABLES COAGULATION TESTING MARKET,2021-2031(%)
    FIGURE 21.COAGULATION TESTING MARKET,BY APPLICATION,2021(%)
    FIGURE 22.COMPARATIVE SHARE ANALYSIS OF PROTHROMBIN TIME COAGULATION TESTING MARKET,2021-2031(%)
    FIGURE 23.COMPARATIVE SHARE ANALYSIS OF ACTIVATED PARTIAL THROMBOPLASTIN TIME COAGULATION TESTING MARKET,2021-2031(%)
    FIGURE 24.COMPARATIVE SHARE ANALYSIS OF THROMBIN TIME COAGULATION TESTING MARKET,2021-2031(%)
    FIGURE 25.COMPARATIVE SHARE ANALYSIS OF ACTIVATED CLOTTING TIME COAGULATION TESTING MARKET,2021-2031(%)
    FIGURE 26.COAGULATION TESTING MARKET,BY END USER,2021(%)
    FIGURE 27.COMPARATIVE SHARE ANALYSIS OF HOSPITALS COAGULATION TESTING MARKET,2021-2031(%)
    FIGURE 28.COMPARATIVE SHARE ANALYSIS OF CLINICAL LABORATORIES COAGULATION TESTING MARKET,2021-2031(%)
    FIGURE 29.COMPARATIVE SHARE ANALYSIS OF POINT-OF-CARE TESTING COAGULATION TESTING MARKET,2021-2031(%)
    FIGURE 30.COMPARATIVE SHARE ANALYSIS OF OTHERS COAGULATION TESTING MARKET,2021-2031(%)
    FIGURE 31.COAGULATION TESTING MARKET BY REGION,2021
    FIGURE 32.U.S. COAGULATION TESTING MARKET,2021-2031($MILLION)
    FIGURE 33.CANADA COAGULATION TESTING MARKET,2021-2031($MILLION)
    FIGURE 34.MEXICO COAGULATION TESTING MARKET,2021-2031($MILLION)
    FIGURE 35.GERMANY COAGULATION TESTING MARKET,2021-2031($MILLION)
    FIGURE 36.UNITED KINGDOM COAGULATION TESTING MARKET,2021-2031($MILLION)
    FIGURE 37.FRANCE COAGULATION TESTING MARKET,2021-2031($MILLION)
    FIGURE 38.SPAIN COAGULATION TESTING MARKET,2021-2031($MILLION)
    FIGURE 39.ITALY COAGULATION TESTING MARKET,2021-2031($MILLION)
    FIGURE 40.REST OF EUROPE COAGULATION TESTING MARKET,2021-2031($MILLION)
    FIGURE 41.CHINA COAGULATION TESTING MARKET,2021-2031($MILLION)
    FIGURE 42.JAPAN COAGULATION TESTING MARKET,2021-2031($MILLION)
    FIGURE 43.INDIA COAGULATION TESTING MARKET,2021-2031($MILLION)
    FIGURE 44.SOUTH KOREA COAGULATION TESTING MARKET,2021-2031($MILLION)
    FIGURE 45.AUSTRALIA COAGULATION TESTING MARKET,2021-2031($MILLION)
    FIGURE 46.REST OF ASIA PACIFIC COAGULATION TESTING MARKET,2021-2031($MILLION)
    FIGURE 47.BRAZIL COAGULATION TESTING MARKET,2021-2031($MILLION)
    FIGURE 48.SAUDI ARABIA COAGULATION TESTING MARKET,2021-2031($MILLION)
    FIGURE 49.UAE COAGULATION TESTING MARKET,2021-2031($MILLION)
    FIGURE 50.SOUTH AFRICA COAGULATION TESTING MARKET,2021-2031($MILLION)
    FIGURE 51.REST OF LAMEA COAGULATION TESTING MARKET,2021-2031($MILLION)
    FIGURE 52. TOP WINNING STRATEGIES, BY YEAR
    FIGURE 53. TOP WINNING STRATEGIES, BY DEVELOPMENT
    FIGURE 54. TOP WINNING STRATEGIES, BY COMPANY
    FIGURE 55.PRODUCT MAPPING OF TOP 10 PLAYERS
    FIGURE 56.COMPETITIVE DASHBOARD
    FIGURE 57.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
    FIGURE 58.ALERE INC..: NET SALES ,($MILLION)
    FIGURE 59.NIHON KOHDEN CORPORATION.: NET SALES ,($MILLION)
    FIGURE 60.F. HOFFMANN-LA ROCHE LTD..: NET SALES ,($MILLION)
    FIGURE 61.SYSMEX CORPORATION.: NET SALES ,($MILLION)
    FIGURE 62.THERMO FISHER SCIENTIFIC INC..: NET SALES ,($MILLION)
    FIGURE 63.DIAGNOSTICA STAGO SAS.: NET SALES ,($MILLION)
    FIGURE 64.HELENA LABORATORIES.: NET SALES ,($MILLION)
    FIGURE 65.ABBOTT LABORATORIES.: NET SALES ,($MILLION)
    FIGURE 66.MEDTRONIC PLC.: NET SALES ,($MILLION)
    FIGURE 67.MICROPOINT BIOSCIENCES.: NET SALES ,($MILLION)

Purchase Full Report of
Coagulation Testing Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved